Clinical Development Hub
Local Demo
Home/regulatory/intelligence

Regulatory Intelligence

Guidance and country intelligence impact tracking. This workspace exists to enforce consistent clinical execution with accountable ownership, governed evidence, and inspection-ready traceability across the study lifecycle. It supports business and regulatory requirements by connecting operations, quality, submissions, and financial controls in a single system where handoffs are explicit and auditable. Users can proceed by filtering scope, reviewing linked artifacts and actions, and routing escalations with defined approval gates and signature meaning.

Regulatory Intelligence Feed

Guidance Updates
128
Impacted Studies
42
Response Plans
35

Guidance Impact Actions

1
INTEL-300 | US
guidance impact high | mapped to STUDY-0001
2
INTEL-301 | CA
guidance impact medium | mapped to STUDY-0002
3
INTEL-302 | GB
guidance impact high | mapped to STUDY-0003
4
INTEL-303 | DE
guidance impact medium | mapped to STUDY-0004
5
INTEL-304 | FR
guidance impact high | mapped to STUDY-0005
6
INTEL-305 | ES
guidance impact medium | mapped to STUDY-0006
7
INTEL-306 | IT
guidance impact high | mapped to STUDY-0007
8
INTEL-307 | NL
guidance impact medium | mapped to STUDY-0008
9
INTEL-308 | BE
guidance impact high | mapped to STUDY-0009
10
INTEL-309 | SE
guidance impact medium | mapped to STUDY-0010
Access & Governance Controls
RBAC+ABACStudy Firewall ActiveRestricted Zone

Operational Controls

Study firewalling chips highlight boundary, country constraints, and vendor partition rules.

Actions requiring GxP control include a human review checkpoint and e-signature meaning capture.

Every state change writes immutable audit evidence with actor, timestamp, and object reference.

Next Actions

Filter to portfolio/program/study context.

Open linked tasks, risks, and document evidence.

Escalate blocked items through governed workflow.